ACS Embraces Home HPV Tests for Cervical Cancer

The American Cancer Society has introduced new guidelines for cervical cancer screening, notably endorsing self-collected vaginal samples for HPV testing. This change, effective since the FDA approved an at-home HPV self-collection test, aims to increase screening participation among women aged 25 and older. While provider-administered tests are still preferred every five years, self-collection every three years offers a convenient alternative, especially for those hesitant to visit a clinic.

This initiative seeks to reverse a two-decade decline in cervical cancer screenings. Experts believe self-collection can overcome barriers such as fear, past negative experiences, or geographical distance from healthcare providers. However, some express concern that the convenience of self-testing might discourage women from attending regular gynecologist appointments, potentially delaying the diagnosis of other health issues.

Additionally, the ACS has clarified recommendations for older women, stating that those who have had two negative co-tests by ages 60 and 65 can cease regular screening. This adjustment aims to reduce confusion around previous guidelines, though it highlights that a quarter of cervical cancer cases occur in women over 65, often at more advanced stages.